Volrustomig
Product Specifications
CAS Number
2407760-40-9
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation, Cell Cycle/Checkpoint, Apoptosis
Bioactivity
Volrustomig is a bi-engineered fragment crystallizable (Fc) domain, a monovalent bispecific IgG1 monoclonal antibody targeting the key immune checkpoint receptors PD-1 and CTLA-4. It boosts T-cell activation and antitumor immunity, making it a promising immunotherapy for various cancers. Molecular weight: 146.77 kDa.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
